TY - JOUR
T1 - Personalized Pain Goals and Responses in Advanced Cancer Patients
AU - Mercadante, Sebastiano
AU - Adile, Claudio
AU - Aielli, Federica
AU - Gaetano, Lanzetta
AU - Mistakidou, Kyriaki
AU - Maltoni, Marco
AU - Soares, Luiz Guilherme
AU - Desantis, Stefano
AU - Ferrera, Patrizia
AU - Rosati, Marta
AU - Rossi, Romina
AU - Casuccio, Alessandra
N1 - Publisher Copyright:
© 2019 American Academy of Pain Medicine. All rights reserved.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Objective: To assess the personalized pain intensity goal (PPIG), the achievement of a personalized pain goal response (PPGR), and patients' global impression (PGI) in advanced cancer patients after a comprehensive pain and symptom management. Design: Prospective, longitudinal Setting: Acute pain relief and palliative/supportive care. Subjects: 689 advanced cancer patients. Methods: Measurement of Edmonton Symptom Assessment Score (ESAS) and personalized pain intensity goal (PPIG) at admission (T0). After a week (T7) personalized pain goal response (PPGR) and patients' global impression (PGI) were evaluated. Results: The mean PPIG was 1.33 (SD 1.59). A mean decrease in pain intensity of - 2.09 was required on PPIG to perceive a minimal clinically important difference (MCID). A better improvement corresponded to a mean change of - 3.41 points, while a much better improvement corresponded to a mean of - 4.59 points. Patients perceived a MCID (little worse) with a mean increase in pain intensity of 0.25, and a worse with a mean increase of 2.33 points. Higher pain intensity at T0 and lower pain intensity at T7 were independently related to PGI. 207 (30.0%) patients achieved PPGR. PPGR was associated with higher PPIG at T0 and T7, and inversely associated to pain intensity at T0 and T7, and Karnofsky level. Patients with high pain intensity at T0 achieved a favorable PGI, even when PPIG was not achieved by PPGR. Conclusion: PPIG, PPGR and PGI seem to be relevant for evaluating the effects of a comprehensive management of pain, assisting decision-making process according to patients' expectations. Some factors may be implicated in determining the individual target and the clinical response.
AB - Objective: To assess the personalized pain intensity goal (PPIG), the achievement of a personalized pain goal response (PPGR), and patients' global impression (PGI) in advanced cancer patients after a comprehensive pain and symptom management. Design: Prospective, longitudinal Setting: Acute pain relief and palliative/supportive care. Subjects: 689 advanced cancer patients. Methods: Measurement of Edmonton Symptom Assessment Score (ESAS) and personalized pain intensity goal (PPIG) at admission (T0). After a week (T7) personalized pain goal response (PPGR) and patients' global impression (PGI) were evaluated. Results: The mean PPIG was 1.33 (SD 1.59). A mean decrease in pain intensity of - 2.09 was required on PPIG to perceive a minimal clinically important difference (MCID). A better improvement corresponded to a mean change of - 3.41 points, while a much better improvement corresponded to a mean of - 4.59 points. Patients perceived a MCID (little worse) with a mean increase in pain intensity of 0.25, and a worse with a mean increase of 2.33 points. Higher pain intensity at T0 and lower pain intensity at T7 were independently related to PGI. 207 (30.0%) patients achieved PPGR. PPGR was associated with higher PPIG at T0 and T7, and inversely associated to pain intensity at T0 and T7, and Karnofsky level. Patients with high pain intensity at T0 achieved a favorable PGI, even when PPIG was not achieved by PPGR. Conclusion: PPIG, PPGR and PGI seem to be relevant for evaluating the effects of a comprehensive management of pain, assisting decision-making process according to patients' expectations. Some factors may be implicated in determining the individual target and the clinical response.
KW - Cancer Pain
KW - Clinical Response
KW - Pain Intensity
UR - http://www.scopus.com/inward/record.url?scp=85076920160&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076920160&partnerID=8YFLogxK
U2 - 10.1093/pm/pnz254
DO - 10.1093/pm/pnz254
M3 - Article
C2 - 31633792
AN - SCOPUS:85076920160
VL - 21
SP - E215-E221
JO - Pain Medicine
JF - Pain Medicine
SN - 1526-2375
IS - 2
ER -